# India Infertility Market

> India Infertility Market Research Report By Sex (Males, Females, Unexplained), By Diagnosis (Men Diagnostic Tests, Women Diagnostic Tests, General Diagnostic Test), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Others) andBy Technology (Assisted Reproductive Technology, Intrauterine Insemination, Surgery) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.82%
- **2024:** $ 152.65 Million
- **2025:** $ 172.22 Million
- **2035:** $ 575.36 Million
- **Key Players:** CooperSurgical (US), Merck KGaA (DE), Ferring Pharmaceuticals (CH), Vitrolife (SE), Irvine Scientific (US), Reproductive Health Technologies (US), OvaScience (US), Genea (AU)

**Report ID:** MRFR/HC/43847-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-infertility-market-45527

---

## Market Summary

## **India Infertility Market Overview**

As per MRFR analysis, the India Infertility Market Size was estimated at 113.01 (USD Million) in 2024The India Infertility Market Industry is expected to grow from 127.5(USD Million) in 2025 to 872.5 (USD Million) by 2035. The India Infertility Market CAGR (growth rate) is expected to be around 19.106% during the forecast period (2025 - 2035).

**Key India Infertility Market Trends Highlighted**

The India Infertility Market is experiencing significant growth driven by rising awareness about reproductive health issues and an increase in infertility rates attributed to lifestyle changes, delayed marriages, and urbanization. As more couples seek assistance, the acceptance of assisted reproductive technologies like in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) is increasing. Furthermore, heightened government initiatives focusing on maternal health underscore a push towards improving fertility treatment access. There are abundant opportunities to be explored within this market, particularly in tier II and III cities where awareness about infertility treatments is still developing.

As healthcare infrastructure improves in these regions, fertility clinics and specialized healthcare providers can capture this underserved segment. The rise of telemedicine also offers a unique avenue for delivering fertility consultations and support, making treatments more accessible to couples in remote areas. Recent trends show a growing inclination towards holistic approaches to fertility, which encompass not just medical treatments but also lifestyle and dietary changes. Additionally, a surge in partnerships between healthcare providers and technology firms is fostering innovative solutions such as mobile applications for tracking fertility cycles.

The collaboration between hospitals and research institutions is also witnessing a boost, resulting in improved research and development of new treatments and therapies. As India continues to prioritize healthcare advancements, the infertility market is likely to see a blend of traditional practices and modern technology working together to meet the needs of individuals seeking fertility solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Infertility Market Drivers**

**Rising Infertility Rates Due to Lifestyle Changes**

In India, the rise in infertility rates can be attributed to various lifestyle changes, including the increasing trend of late marriages, sedentary lifestyles, and unhealthy dietary habits. According to the Indian Society of Assisted Reproduction, the fertility rate has been declining, with studies indicating that approximately 10-15% of couples experience infertility issues. This statistic is compounded by urbanization and the growing preference for nuclear families.With the modernization of lifestyles, factors such as increased stress levels and environmental exposures have been recognized as critical contributors to infertility.

As awareness grows about these issues, the India Infertility Market Industry is likely to see an increased demand for assisted reproductive technology (ART) and fertility treatments, driven by couples seeking solutions to combat these challenges.

**Government Initiatives and Policy Support**

The Indian government has recognized the importance of addressing infertility as a public health issue. Initiatives such as the National Health Mission and various health policies aim to promote reproductive health services, which have positive implications for the India Infertility Market Industry. Furthermore, supportive policies for the establishment and regulation of fertility clinics and the rising number of ART centers across the nation are easing accessibility for couples.By 2022, the Ministry of Health and Family Welfare reported the establishment of over 400 ART clinics across India, which illustrates a commitment to improving fertility services and ultimately driving market growth.

**Technological Advancements in Fertility Treatments**

Technological advancements in fertility treatments are a significant driver of the India Infertility Market Industry's growth. Innovations such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) have revolutionized reproduction options. The increasing availability and affordability of these technologies have led to a higher success rate of treatments, attracting more couples to seek help.Reports from the Reproductive Health Unit have noted that the success rate of IVF treatments has reached up to 50-60% for women under 35. This improvement in success rates significantly boosts patient confidence and contributes to market expansion.

**Increased Awareness and Acceptance of Fertility Treatments**

Over the past decade, there has been a marked increase in awareness and social acceptance surrounding infertility and fertility treatments in India. Educational campaigns initiated by healthcare providers and organized groups have played a vital role in destigmatizing fertility issues, enabling couples to seek assistance without social apprehensions.

According to the Rs. 12,000 crore study by the Indian Council of Medical Research on reproductive health, it was found that more than 80% of individuals are open to the idea of seeking ART-related services when fertility issues arise.This newfound openness and the growing demand for treatment options are directly contributing to the India Infertility Market Industry's prospects.

**India Infertility Market Segment Insights**

**Infertility Market Sex Insights**

The India Infertility Market, particularly focusing on the aspect of Sex, is gaining considerable attention due to rising issues related to infertility among couples. Factors contributing to the escalating demand for infertility treatments include urbanization, lifestyle changes, and an increased awareness of reproductive health. The market exhibits a notable segmentation in terms of the characteristics of male and female infertility, as well as cases classified as unexplained infertility. 

This delineation is critical as it allows for targeted treatment strategies and better patient management.In recent years, the male infertility segment has drawn significant attention, given that a considerable proportion of infertility cases are attributed to male factors. Conditions such as low sperm count and motility are becoming increasingly recognized, pushing the industry to focus more on male reproductive health. On the other hand, the female infertility segment continues to be a dominant player, with a diverse array of causes ranging from polycystic ovary syndrome (PCOS) to advanced age, leading to a greater demand for assisted reproductive technologies.

Additionally, unexplained infertility remains a perplexing challenge that impacts many couples, emphasizing the need for advanced diagnostic technologies and solutions tailored to ensure successful conception. As awareness and education around infertility in India grow, coupled with advancements in medical technology and treatment methodologies, the overall India Infertility Market shows potential for significant developments in addressing these conditions effectively. The interplay of societal perceptions, medical advancements, and individual experiences shapes the landscape of infertility in India, resulting in a continuously evolving market that holds promise for better healthcare solutions tailored around these critical segments.

Furthermore, government initiatives and health programs focusing on reproductive health are expected to facilitate enhanced access to infertility treatments, further contributing to market expansion. Overall, the India Infertility Market continues to reflect dynamic trends and opportunities, with its focus on Sex providing extensive insights into the varying needs and preferences of those affected by infertility.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Infertility Market Diagnosis Insights**

The Diagnosis segment of the India Infertility Market encompasses a variety of testing services aimed at identifying the underlying causes of infertility in both men and women. This segment is crucial as it forms the basis for effective treatment strategies. Men Diagnostic Tests focus on evaluating sperm quality, motility, and overall reproductive health, which is essential considering that male factors contribute to nearly half of all infertility cases in India.

Women Diagnostic Tests, on the other hand, assess ovulation, hormonal balance, and structural anomalies which are equally important, given that a significant portion of infertility issues arise from female reproductive health.

General Diagnostic Tests provide a comprehensive approach to fertility evaluation, integrating both male and female assessments, thus playing a significant role in guiding couples through their fertility journey. The increasing awareness of reproductive health and advancements in diagnostic technologies are driving growth in this segment, highlighting the necessity for accurate and timely diagnosis as a critical first step in the infertility treatment process within the broader India Infertility Market landscape.

**Infertility Market Drugs Insights**

The Drugs segment within the India Infertility Market plays a pivotal role in addressing the rising concerns of infertility in the region, influenced by factors such as lifestyle changes and increasing awareness about reproductive health. Within this segment, Clomiphene Citrate and Letrozole are notable for their effectiveness in stimulating ovulation, making them essential for couples facing challenges in conceiving. Hormone Treatment is crucial for individuals with hormonal imbalances, contributing significantly to treatment outcomes. Moreover, Serophene serves as a vital medication for triggering ovulation and restoring the reproductive cycle.

The market for these treatments reflects a growing acceptance and innovation in reproductive health solutions, seen in the increasing demand for fertility drugs across various demographics. The significance of these medications is further enhanced by supportive government policies that aim to improve healthcare accessibility, making these drugs an integral part of the healthcare narrative in India. Overall, the Drugs segment is poised for growth, driven by advancements in medical technologies and the growing pool of patients seeking effective infertility treatments.

**Infertility Market Technology Insights**

The Technology segment of the India Infertility Market plays a crucial role in improving reproductive health and offering solutions to couples facing challenges in conceiving. This segment encompasses various advanced techniques, including Assisted Reproductive Technology (ART), Intrauterine Insemination (IUI), and surgical interventions aimed at enhancing fertility. Assisted Reproductive Technology stands out as a significant contributor, providing options like in vitro fertilization (IVF) that assist many couples in overcoming infertility issues.IUI is also essential, as it offers a less invasive approach, enabling quicker conception opportunities for many. 

Surgical methods, on the other hand, are vital for addressing underlying reproductive health issues, significantly improving the chances of successful pregnancies. The growing prevalence of infertility in India, driven by factors such as changing lifestyles and delayed childbearing, continues to bolster the demand for these innovative technologies. With increased access and affordability, particularly in urban areas, the Technology segment of the India Infertility Market presents expansive growth opportunities, making it an integral part of the healthcare ecosystem.As awareness increases and societal perceptions shift, the usage of these technologies is expected to rise, supporting couples in their journey towards parenthood.

**India Infertility Market Key Players and Competitive Insights**

The India Infertility Market has experienced significant growth in recent years, driven by increasing awareness about infertility issues, advancements in reproductive technology, and evolving societal norms regarding family planning. With a large population seeking effective solutions for reproductive health challenges, the market is characterized by a mix of established players and emerging clinics offering innovative treatments. Competitive insights reveal that the industry is highly dynamic, with organizations increasingly focusing on customer-centric approaches, personalized treatment plans, and cutting-edge technology to enhance success rates.

Furthermore, factors such as partnerships with healthcare providers, investments in research and development, and marketing strategies have become essential for gaining a competitive edge in this burgeoning field.

Max Healthcare stands out in the India Infertility Market due to its comprehensive services and strong market presence. Known for its extensive network of clinics and hospitals, Max Healthcare emphasizes a patient-centric approach, providing tailored infertility treatments that cater to the diverse needs of couples facing reproductive challenges. The organization's strength lies in its experienced medical professionals and support staff, which contribute to high success rates in assisted reproductive technologies such as IVF and IUI.

Max Healthcare's commitment to quality care, combined with state-of-the-art facilities and a focus on continuous improvement, allows it to maintain a leading position in the competitive landscape. Additionally, collaborations with leading medical researchers and institutions further bolster its reputation as a trusted provider in the infertility sector.

Bourn Hall Fertility Clinic is another formidable player in the India Infertility Market, recognized for its pioneering approach reproductive medicine. The clinic offers a range of services including IVF, egg freezing, and fertility preservation, which are tailored to meet the specific needs of individuals and couples. Bourn Hall has established a strong presence in the country by focusing on patient education and transparency, thereby enhancing patient trust and satisfaction. 

The organization's strengths are derived from its highly trained specialists and cutting-edge laboratory facilities, enabling it to achieve impressive success rates. Additionally, Bourn Hall has pursued strategic partnerships and collaborations within the healthcare ecosystem, allowing it to expand its service offerings and reach. This ongoing commitment to innovation, combined with a patient-first ethos, positions Bourn Hall Fertility Clinic as a key player in the Indian infertility market landscape.

**Key Companies in the India Infertility Market Include**

**India Infertility Market Industry Developments**

In recent months, the India Infertility Market has witnessed significant developments. Notably, in May 2023, Max Healthcare announced the opening of a new fertility clinic in Delhi, expanding its reach in assisted reproductive technologies. Bourn Hall Fertility Clinic also introduced advanced IVF services in Vadodara in June 2023, demonstrating its commitment to innovative treatments. Additionally, Nova IVF has been actively engaging in partnerships with local hospitals to enhance patient accessibility, strengthening its market presence.

On the merger and acquisition front, Indira IVF was reported to have acquired a small chain of fertility clinics in Punjab in April 2023, bolstering its capacity and geographic footprint. The market is experiencing robust growth, with the valuation of major companies like Cloudnine and Kiran Hospital seeing a notable increase due to rising awareness and advancements in fertility treatments. Over the past couple of years, companies like Manipal Fertility and Ziva Fertility have also enhanced their service offerings to cater to the growing demand in India, where government initiatives are actively promoting reproductive health.

Furthermore, certain states are implementing policies to improve access to infertility treatments for couples across various socio-economic strata.

**India Infertility Market Segmentation Insights**

**Infertility Market****Sex****Outlook**

**Infertility Market****Diagnosis****Outlook**

**Infertility Market****Drugs****Outlook**

**Infertility Market****Technology****Outlook**

## Market Drivers

### Rising Disposable Income

The increase in disposable income among the Indian population is a significant driver for the infertility market. As more individuals attain higher income levels, they are more likely to invest in healthcare services, including fertility treatments. This trend is particularly evident in urban areas, where couples are increasingly prioritizing family planning and reproductive health. The affordability of advanced treatments is expected to improve, leading to a higher demand for services in the infertility market. Market analysts suggest that this trend could result in a substantial increase in the number of couples opting for ART, further propelling market growth.

### Increasing Infertility Rates

The rising infertility rates in India are a primary driver for the infertility market. Recent data indicates that approximately 15% of couples in India experience infertility, which translates to millions of individuals seeking assistance. Factors contributing to this trend include lifestyle changes, delayed marriages, and increased stress levels. As societal norms evolve, more couples are opting for assisted reproductive technologies (ART), thereby expanding the market. The infertility market is projected to grow significantly, with estimates suggesting a compound annual growth rate (CAGR) of around 20% over the next few years. This growth is likely to be fueled by the increasing number of fertility clinics and the availability of advanced treatment options.

### Cultural Shifts and Acceptance

Cultural shifts in India are influencing perceptions surrounding infertility and its treatment. Traditionally, infertility was often stigmatized, but there appears to be a growing acceptance of seeking medical help. This change is likely driven by increased awareness and education about reproductive health. As more individuals openly discuss infertility, the demand for services in the infertility market is expected to rise. Furthermore, the integration of fertility treatments into mainstream healthcare is fostering a more supportive environment for couples facing infertility challenges. This cultural evolution may lead to a broader acceptance of ART, thereby enhancing market growth.

### Advancements in Medical Technology

Technological advancements in reproductive medicine are significantly impacting the infertility market. Innovations such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) are becoming more accessible to couples in India. The introduction of these advanced techniques is likely to improve success rates, thereby attracting more patients to fertility clinics. Additionally, the cost of these technologies is gradually decreasing, making them more affordable for a larger segment of the population. As a result, the infertility market is expected to expand, with a projected increase in the number of procedures performed annually.

### Government Initiatives and Policies

Government initiatives aimed at addressing infertility issues are playing a crucial role in shaping the infertility market. Various state and national programs are being implemented to promote awareness about reproductive health and provide financial assistance for fertility treatments. For instance, certain states have introduced subsidies for couples undergoing IVF, which could potentially increase access to these services. Furthermore, regulatory frameworks are being established to ensure the quality and safety of fertility clinics. These government efforts are likely to enhance public trust in the infertility market, encouraging more couples to seek treatment.

## Future Outlook

The [Infertility Market](https://www.marketresearchfuture.com/reports/infertility-market-6145) in India is projected to grow at a 12.82% CAGR from 2025 to 2035, driven by increasing awareness, technological advancements, and rising disposable incomes.

**New opportunities:**

- Expansion of telemedicine services for remote consultations
- Development of personalized fertility treatment plans
- Investment in AI-driven diagnostic tools for infertility assessment

By 2035, the infertility market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Assisted Reproductive Technology (Largest) vs. Hormone Therapy (Fastest-Growing)

The distribution of market share among the segment values in the India infertility market shows Assisted Reproductive Technology as the predominant player, capturing the largest portion of the market. Following this, Hormone Therapy is recognized as a significant contributor, while Surgery and Fertility Preservation also hold their respective shares, albeit smaller in comparison. This segmentation highlights the varying demand and the specialized nature of each treatment type.

Growth trends in the India infertility market indicate a surge in the popularity of Assisted Reproductive Technology, driven by increasing awareness and advancements in medical technologies. Hormone Therapy is emerging rapidly, attributed to its accessibility and effectiveness for many individuals. Additionally, factors such as changing lifestyles, delayed marriages, and rising infertility rates are propelling overall growth across all segments, making it an active and evolving market.

Assisted Reproductive Technology (Dominant) vs. Surgery (Emerging)

Assisted Reproductive Technology stands out as the dominant force in the India infertility market due to its comprehensive range of services, including In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI). These methods have gained wide acceptance owing to their success rates and are preferred by many couples facing infertility challenges. In contrast, Surgery is considered an emerging segment, focusing on addressing underlying reproductive issues through invasive procedures. Although it holds a smaller share, the increasing prevalence of conditions like endometriosis and fibroids is driving more patients towards surgical solutions, making it a notable player in the market landscape.

### By End User: Hospitals (Largest) vs. Fertility Clinics (Fastest-Growing)

In the India infertility market, the distribution of market share among end users reveals that hospitals hold the largest segment share, primarily due to their established infrastructure and comprehensive service offerings. Fertility clinics follow closely behind, capturing a significant portion of the market with their specialized services tailored for infertility treatments, making them a critical player in the competitive landscape.

The growth trends in the end user segment are characterized by the rapid expansion of fertility clinics, which cater to the increasing demand for personalized and advanced reproductive technologies. This surge is driven by rising consumer awareness, coupled with the growing acceptance of fertility treatments in society. Additionally, the increasing number of individuals seeking assistance for infertility issues propels both hospitals and clinics to innovate and enhance service delivery, ensuring they meet evolving patient needs.

Hospitals (Dominant) vs. Fertility Clinics (Emerging)

Hospitals are viewed as the dominant end user in the India infertility market, providing a broad spectrum of services ranging from diagnostics to complex reproductive surgeries. Their extensive resources and multidisciplinary teams enable them to handle various infertility cases, resulting in a high patient trust level. On the other hand, fertility clinics are emerging as strong competitors, focusing on specific fertility treatments such as in vitro fertilization (IVF) and hormonal therapies. These clinics offer personalized care and flexible treatment plans, attracting an increasing number of patients who prefer specialized services. As competition intensifies, collaboration between hospitals and fertility clinics is becoming essential to enhance service delivery and improve patient outcomes.

### By Gender: Female (Largest) vs. Male (Fastest-Growing)

In the India infertility market, the distribution of market share between genders shows that the female segment holds a dominant position. Female-related infertility treatments comprise a significant portion of the services offered, reflecting the greater awareness and prevalence of female infertility issues compared to male infertility. While female infertility has long been recognized, the growing visibility of male-related factors has recently begun to shift the dynamics, although the female segment remains more substantial in share.

Growth trends indicate that the male segment is emerging as the fastest-growing segment in the India infertility market. This surge is driven by increased awareness about male infertility factors, improved diagnostic techniques, and evolving societal perceptions regarding men's reproductive health. As awareness campaigns and fertility treatments geared towards men gain traction, the market is expected to witness a marked increase in demand for male infertility services in the coming years.

Female (Dominant) vs. Male (Emerging)

The female segment of the India infertility market is characterized by a comprehensive range of treatments, including ovulation induction, in vitro fertilization (IVF), and other assisted reproductive technologies (ART). Females traditionally take center stage in infertility discussions, resulting in a well-established market with a strong network of clinics and healthcare providers. In contrast, the male segment, while previously overlooked, is rapidly evolving. Specific conditions such as low sperm count and other male infertility issues are gaining attention, leading to increased research and development of targeted therapies. This shift is creating a balance in the market, wherein both genders are increasingly recognized in the broader conversation about fertility.

### By Cause of Infertility: Ovulatory Disorders (Largest) vs. Male Factor Infertility (Fastest-Growing)

In the India infertility market, the distribution of market share among the causes of infertility reveals that ovulatory disorders constitute the largest segment. This condition, characterized by irregular or absent ovulation, significantly impacts female fertility and encompasses a major portion of the overall infertility cases. Following this, male factor infertility, which involves issues related to sperm quality and production, is gaining traction, capturing a growing segment of the market share.

Growth trends within the India infertility market indicate a rising awareness and understanding of male factor infertility, underscoring its importance in fertility discussions. Innovative treatments and diagnostic procedures specifically targeting male infertility are becoming increasingly prominent. Furthermore, a societal shift in attitudes towards male reproductive health is driving demand, making it the fastest-growing segment as couples seek comprehensive solutions to address infertility challenges together.

Ovulatory Disorders: Dominant vs. Male Factor Infertility: Emerging

Ovulatory disorders are a dominant force in the India infertility market, often attributed to hormonal imbalances, lifestyle factors, and stress, which significantly affect women's reproductive capabilities. The segment is characterized by its well-established treatment options, including hormonal therapies and lifestyle interventions, towards improving ovulation rates. On the other hand, male factor infertility emerges as a crucial segment, reflecting increased research and emphasis on male reproductive health. This segment is characterized by advancements in sperm analysis and treatments such as in vitro fertilization (IVF) specifically designed to address male infertility issues. The growing recognition of male factors in reproductive health discussions has spurred investment and innovation, propelling it into prominence within the market.

## Competitive Benchmarking

The infertility market exhibits a dynamic competitive landscape, characterized by a blend of innovation, strategic partnerships, and regional expansion. Key players such as CooperSurgical (US), Merck KGaA (DE), and Ferring Pharmaceuticals (CH) are at the forefront, each adopting distinct strategies to enhance their market presence. CooperSurgical (US) focuses on expanding its product portfolio through innovative solutions, while Merck KGaA (DE) emphasizes research and development to drive technological advancements in reproductive health. Ferring Pharmaceuticals (CH) is actively pursuing strategic collaborations to enhance its therapeutic offerings, thereby shaping a competitive environment that is increasingly reliant on innovation and strategic alliances.The business tactics employed by these companies reflect a concerted effort to optimize operations and enhance market positioning. Localizing manufacturing and optimizing supply chains are prevalent strategies aimed at reducing costs and improving service delivery. The market structure appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies is significant in shaping industry standards and practices.

In September  Merck KGaA (DE) announced a partnership with a leading Indian fertility clinic to enhance access to its advanced reproductive technologies. This collaboration is poised to expand Merck's footprint in the Indian market, allowing for localized solutions that cater to the specific needs of patients. The strategic importance of this partnership lies in its potential to increase market penetration and foster brand loyalty among healthcare providers and patients alike.

In October  Ferring Pharmaceuticals (CH) launched a new fertility treatment aimed at improving success rates in assisted reproductive technologies. This product introduction is significant as it underscores Ferring's commitment to innovation and its focus on addressing unmet medical needs in the infertility sector. By enhancing treatment options, Ferring positions itself as a leader in the market, potentially increasing its competitive edge.

In August  CooperSurgical (US) expanded its operations by acquiring a local biotechnology firm specializing in reproductive health solutions. This acquisition is strategically important as it not only broadens CooperSurgical's product offerings but also enhances its research capabilities, allowing for the development of cutting-edge technologies tailored to the Indian market. Such moves indicate a trend towards consolidation in the industry, where companies seek to bolster their competitive positions through strategic acquisitions.

As of November  the infertility market is increasingly defined by trends such as digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are becoming pivotal in shaping the competitive landscape, as companies collaborate to leverage each other's strengths. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly complex market.

## Recent News & Developments

In recent months, the India Infertility Market has witnessed significant developments. Notably, in May 2023, Max Healthcare announced the opening of a new fertility clinic in Delhi, expanding its reach in assisted reproductive technologies. Bourn Hall Fertility Clinic also introduced advanced IVF services in Vadodara in June 2023, demonstrating its commitment to innovative treatments. Additionally, Nova IVF has been actively engaging in partnerships with local hospitals to enhance patient accessibility, strengthening its market presence.

On the merger and acquisition front, Indira IVF was reported to have acquired a small chain of fertility clinics in Punjab in April 2023, bolstering its capacity and geographic footprint. The market is experiencing robust growth, with the valuation of major companies like Cloudnine and Kiran Hospital seeing a notable increase due to rising awareness and advancements in fertility treatments. Over the past couple of years, companies like Manipal Fertility and Ziva Fertility have also enhanced their service offerings to cater to the growing demand in India, where government initiatives are actively promoting reproductive health.

Furthermore, certain states are implementing policies to improve access to infertility treatments for couples across various socio-economic strata.

## Report Scope

| MARKET SIZE 2024 | 152.65(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 172.22(USD Million) |
| MARKET SIZE 2035 | 575.36(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.82% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | CooperSurgical (US), Merck KGaA (DE), Ferring Pharmaceuticals (CH), Vitrolife (SE), Irvine Scientific (US), Reproductive Health Technologies (US), OvaScience (US), Genea (AU) |
| Segments Covered | Type, End User, Gender, Cause of Infertility |
| Key Market Opportunities | Emergence of advanced reproductive technologies and increasing awareness drive growth in the infertility market. |
| Key Market Dynamics | Rising demand for assisted reproductive technologies drives innovation and competition in the infertility market. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What was the overall market valuation of the India infertility market in 2024?**
A: The overall market valuation was $152.65 Million in 2024.

**Q: What is the projected market valuation for the India infertility market by 2035?**
A: The projected valuation for 2035 is $575.36 Million.

**Q: What is the expected CAGR for the India infertility market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period 2025 - 2035 is 12.82%.

**Q: Which segment had the highest valuation in 2024 within the India infertility market?**
A: Fertility Preservation had the highest valuation at $50.02 Million in 2024.

**Q: What are the key players in the India infertility market?**
A: Key players include CooperSurgical, Merck KGaA, Ferring Pharmaceuticals, and Vitrolife.

**Q: How did the Assisted Reproductive Technology segment perform in 2024?**
A: The Assisted Reproductive Technology segment was valued at $45.79 Million in 2024.

**Q: What is the valuation of the Fertility Clinics segment in 2024?**
A: The Fertility Clinics segment was valued at $62.65 Million in 2024.

**Q: Which gender accounted for a higher market valuation in the India infertility market in 2024?**
A: Females accounted for a higher market valuation of $91.325 Million in 2024.

**Q: What was the valuation of Male Factor Infertility in 2024?**
A: Male Factor Infertility was valued at $77.12 Million in 2024.

**Q: What is the projected growth trend for the India infertility market in the coming years?**
A: The market is expected to grow significantly, reaching $575.36 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-infertility-market-45527*